Nu Skin Enterprises (NYSE:NUS)‘s stock had its “buy” rating reaffirmed by equities researchers at Jefferies Financial Group in a research report issued to clients and investors on Tuesday. They presently have a $98.00 price target on the stock. Jefferies Financial Group’s price target points to a potential upside of 22.35% from the stock’s current price.
The analysts wrote, “We hosted NUS senior leaders for a series of meetings last week. While our view of China macro beauty has tempered somewhat in recent months, we walked away from meetings with a more optimistic sense of China skincare device sales potential and global benefits from product innovation (new & extensions), program enhancements (including sales comp structure), and a growing level of sophistication around social selling that sets NUS apart from other MLM companies.””
NUS has been the subject of several other research reports. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price target for the company in a report on Monday, August 6th. ValuEngine downgraded shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 6th. Finally, Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their price target for the company from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $85.33.
Shares of NUS traded up $0.01 during midday trading on Tuesday, hitting $80.10. 835 shares of the stock traded hands, compared to its average volume of 404,429. Nu Skin Enterprises has a 1-year low of $59.31 and a 1-year high of $88.68. The company has a market cap of $4.43 billion, a price-to-earnings ratio of 24.80, a price-to-earnings-growth ratio of 2.27 and a beta of 1.11. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.19 and a current ratio of 1.82.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $1.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.18. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The company had revenue of $704.19 million during the quarter, compared to the consensus estimate of $642.16 million. During the same quarter in the previous year, the company posted $0.77 earnings per share. The company’s revenue for the quarter was up 28.0% compared to the same quarter last year. analysts predict that Nu Skin Enterprises will post 3.61 EPS for the current year.
In related news, General Counsel D Matthew Dorny sold 3,500 shares of Nu Skin Enterprises stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $77.65, for a total transaction of $271,775.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Joseph Y. Chang sold 10,600 shares of Nu Skin Enterprises stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $82.13, for a total transaction of $870,578.00. Following the sale, the insider now owns 63,416 shares in the company, valued at $5,208,356.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,350 shares of company stock worth $3,961,758. Company insiders own 3.00% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of NUS. BlackRock Inc. raised its stake in shares of Nu Skin Enterprises by 11.5% during the second quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock valued at $480,352,000 after purchasing an additional 635,246 shares in the last quarter. Millennium Management LLC raised its position in Nu Skin Enterprises by 937.5% in the first quarter. Millennium Management LLC now owns 422,098 shares of the company’s stock worth $31,113,000 after acquiring an additional 381,414 shares in the last quarter. Renaissance Technologies LLC raised its position in Nu Skin Enterprises by 51.1% in the second quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock worth $63,647,000 after acquiring an additional 275,200 shares in the last quarter. Acadian Asset Management LLC raised its position in Nu Skin Enterprises by 112.2% in the second quarter. Acadian Asset Management LLC now owns 368,804 shares of the company’s stock worth $28,834,000 after acquiring an additional 194,990 shares in the last quarter. Finally, OppenheimerFunds Inc. raised its position in Nu Skin Enterprises by 1,497.3% in the first quarter. OppenheimerFunds Inc. now owns 148,041 shares of the company’s stock worth $10,912,000 after acquiring an additional 138,773 shares in the last quarter. Institutional investors and hedge funds own 76.01% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
See Also: Trading Penny Stocks
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.